Alfredo Molinolo

Title: The Innovations of Alfredo Molinolo

Introduction

Alfredo Molinolo is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of medical science, particularly in the prevention and detection of diseases related to cancer treatment. With a total of 2 patents, his work has the potential to impact patient care and treatment outcomes.

Latest Patents

Molinolo's latest patents include innovative methods aimed at improving the quality of life for patients undergoing radiation therapy or chemotherapy. One of his patents focuses on methods of preventing the development of mucositis, a painful condition that can arise during cancer treatments. This method involves administering an effective amount of a mammalian target of rapamycin (mTOR) inhibitor, such as rapamycin, to the subject. Additionally, he has developed a method for identifying desmoglein-3 (DSG-3) as a biomarker for detecting metastasis in lymph nodes. This method allows for the direct determination of DSG-3 protein levels in samples, aiding in the selection of appropriate therapies based on the presence of metastasis.

Career Highlights

Molinolo works for the United States of America, as Represented by the Secretary, Department of Health and Human Services. His role in this esteemed organization underscores his commitment to advancing healthcare through innovative research and development.

Collaborations

Throughout his career, Molinolo has collaborated with esteemed colleagues such as J Silvio Gutkind and Vyomesh Patel. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in medical science.

Conclusion

Alfredo Molinolo's contributions to the field of medical innovation are noteworthy and impactful. His patents reflect a dedication to improving patient outcomes and advancing the understanding of disease mechanisms. Through his work, he continues to pave the way for future advancements in healthcare.